La CROI - Conference on Retroviruses and Opportunistic Infections, un forum dédié aux scientifiques en recherche fondamentale et recherche clinique, organisent :
the 28th Conference
on Retroviruses and Opportunistic Infections
du 6 au 10 mars 2021
Les sessions en direct commenceront à 10h00 Eastern Time (US) chaque jour
(à 16h CET)
The Conference on Retroviruses and Opportunistic Infections (CROI) was established in 1993 to provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases. The synergy of basic science and clinical investigation has been a major contributor to the success of the meeting. CROI has facilitated the presentation of important discoveries in the field, thereby accelerating progress in HIV and AIDS research. As always, the best and most consequential original research will define the science at virtual CROI 2021 (vCROI 2021), which will include research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions.
Attendance at the conference is open to researchers and clinical educators actively involved in the study and management of HIV, other retroviruses, and related medical conditions.
Live and on-demand sessions from CROI 2021 will be available to registered attendees during the conference. Thereafter, recordings of live and on-demand sessions will be available to nonregistrants only through a paid subscription. For more information, visit the CROI resources page.
Programme prévisionnel :
Le programme inclut notamment la participation des chercheurs français :
- Advances in Biomedical Prevention for HIV and SARS-CoV-2 – Jean-Michel Molina, University of Paris, Paris, France
- François Dabis, University Bordeaux Segalen, Bordeaux, France
- Karine Lacombe, Saint-Antoine Hospital, Paris, France
Le programme des 5 journées est disponible et régulièrement mis à jour sur le site du CROI.
L'inscription est payante et obligatoire sur le site dédié.